MedTrace Logo

Rhodiola Rosea for Mental and Physical Fatigue

NCT01278992 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2011-02-15

No results posted yet for this study

Summary

The primary objective of this trial is to assess whether Rhodiola rosea improves fatigue when compared to placebo in nurses involved in shift work.

Conditions

Interventions

DIETARY_SUPPLEMENT

Rhodiola rosea

1 capsule = 182 mg Rhodiola rosea extract standardized to 2.8% total rosavins. Take 2 capsules at start of wakeful period each day. Participants will self-determine need for second dose, of 1 capsule, within 4 hours of the initial dose.

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER

  • Government of Alberta

    lead OTHER_GOV

Principal Investigators

  • Sunita Vohra, MD FRCPC MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278992 on ClinicalTrials.gov